HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Jinliang Xing Selected Research

Tricarboxylic Acids

9/2015Genetic variations in genes of metabolic enzymes predict postoperational prognosis of patients with colorectal cancer.
2/2015Genetic variants in genes of tricarboxylic acid cycle key enzymes are associated with prognosis of patients with non-small cell lung cancer.
1/2015Polymorphisms in Genes of Tricarboxylic Acid Cycle Key Enzymes Are Associated with Early Recurrence of Hepatocellular Carcinoma.
12/2014Genetic variants in genes of tricarboxylic acid cycle key enzymes predict postsurgical overall survival of patients with hepatocellular carcinoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Jinliang Xing Research Topics

Disease

67Neoplasms (Cancer)
06/2022 - 03/2007
36Hepatocellular Carcinoma (Hepatoma)
01/2022 - 05/2006
14Colorectal Neoplasms (Colorectal Cancer)
01/2022 - 07/2011
14Neoplasm Metastasis (Metastasis)
08/2020 - 05/2009
8Carcinogenesis
06/2022 - 03/2007
5Lung Neoplasms (Lung Cancer)
05/2022 - 03/2007
5Breast Neoplasms (Breast Cancer)
01/2019 - 07/2011
4Glioma (Gliomas)
09/2019 - 10/2010
4Infections
04/2016 - 05/2012
3Liver Neoplasms (Liver Cancer)
01/2022 - 07/2013
3Liver Cirrhosis (Hepatic Cirrhosis)
10/2015 - 05/2015
3Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
09/2015 - 06/2008
3Fibrosis (Cirrhosis)
06/2015 - 09/2012
3Urinary Bladder Neoplasms (Bladder Cancer)
01/2012 - 03/2007
2Mitochondrial Diseases (Mitochondrial Disease)
06/2022 - 01/2019
2Renal Cell Carcinoma (Grawitz Tumor)
01/2022 - 08/2008
2Inflammation (Inflammations)
01/2021 - 01/2019
2Ovarian Neoplasms (Ovarian Cancer)
01/2020 - 01/2020
2Diabetic Cardiomyopathies
01/2020 - 01/2017
2Hypoxia (Hypoxemia)
05/2015 - 08/2012
2Anemia
11/2014 - 07/2013
2Adenocarcinoma
01/2012 - 09/2009
1Small Cell Lung Carcinoma (Small Cell Lung Cancer)
05/2022
1Hepatoblastoma
01/2022
1Insulin Resistance
03/2021
1Obesity
03/2021
1Colitis-Associated Neoplasms
01/2021
1Colitis
01/2021
1Hepatitis
09/2020
1Pancreatic Neoplasms (Pancreatic Cancer)
01/2019

Drug/Important Bio-Agent (IBA)

23Mitochondrial DNA (mtDNA)IBA
06/2022 - 08/2008
11Biomarkers (Surrogate Marker)IBA
05/2022 - 03/2007
8DNA (Deoxyribonucleic Acid)IBA
01/2022 - 06/2008
8EnzymesIBA
10/2019 - 01/2012
7Pharmaceutical PreparationsIBA
01/2022 - 12/2015
6Proteins (Proteins, Gene)FDA Link
05/2022 - 03/2005
5Cell-Free Nucleic AcidsIBA
01/2022 - 01/2017
5CalciumIBA
01/2021 - 10/2017
4Fatty Acids (Saturated Fatty Acids)IBA
01/2022 - 12/2015
4Glucose (Dextrose)FDA LinkGeneric
11/2021 - 12/2016
4Biological ProductsIBA
08/2020 - 10/2015
4Telomerase (Telomerase Reverse Transcriptase)IBA
08/2020 - 03/2007
4Messenger RNA (mRNA)IBA
01/2019 - 06/2008
4Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
10/2015 - 01/2012
4Tricarboxylic AcidsIBA
09/2015 - 12/2014
3Transcription Factors (Transcription Factor)IBA
01/2022 - 08/2012
33- (2,4- dichloro- 5- methoxyphenyl)- 2- sulfanyl- 4(3H)- quinazolinoneIBA
01/2018 - 01/2016
3Glycoproteins (Glycoprotein)IBA
12/2015 - 05/2009
3MicroRNAs (MicroRNA)IBA
11/2013 - 09/2009
2Peptides (Polypeptides)IBA
05/2022 - 03/2021
2Tumor Biomarkers (Tumor Markers)IBA
05/2022 - 03/2021
2mitochondrial transcription factor AIBA
01/2021 - 01/2018
2RNA (Ribonucleic Acid)IBA
08/2020 - 01/2011
2LipidsIBA
01/2020 - 09/2019
2Reactive Oxygen Species (Oxygen Radicals)IBA
10/2019 - 01/2018
2Small Interfering RNA (siRNA)IBA
09/2019 - 05/2015
2ParvalbuminsIBA
03/2019 - 03/2018
2mitochondrial calcium uniporterIBA
03/2019 - 01/2018
2Hormones (Hormone)IBA
01/2015 - 11/2014
2Matrix Metalloproteinases (MMPs)IBA
10/2010 - 05/2009
2MutagensIBA
10/2010 - 03/2007
1Carcinoembryonic AntigenIBA
05/2022
1big gastrinIBA
05/2022
1squamous cell carcinoma-related antigenIBA
05/2022
1pro-gastrin-releasing peptide (31-98)IBA
05/2022
1Phosphopyruvate Hydratase (Enolase)IBA
05/2022
1Keratin-19 (Keratin 19)IBA
05/2022
1hydrogen sulfite (bisulfite)IBA
01/2022
1Sirtuin 1IBA
01/2022
1TFXIBA
11/2021
1AzoxymethaneIBA
01/2021
1Dextran SulfateIBA
01/2021
1Circulating Tumor DNAIBA
06/2020
1Terfenadine (Seldane)IBA
01/2020
1Adenosine Monophosphate (AMP)IBA
01/2020
1Histamine Receptors (Histamine Receptor)IBA
01/2020
1Cyclic AMP-Dependent Protein Kinases (cAMP-Dependent Protein Kinase)IBA
01/2020
1Matrix Metalloproteinase 2 (Gelatinase A)IBA
01/2020
1CholesterolIBA
01/2020
1A Kinase Anchor ProteinsIBA
01/2020
1IronIBA
09/2019
1Phospholipid Hydroperoxide Glutathione PeroxidaseIBA
09/2019
1Protein Kinases (Protein Kinase)IBA
09/2019
1Phosphotransferases (Kinase)IBA
09/2019
1Activating Transcription Factor 4IBA
09/2019
1artenimol (dihydroartemisinin)IBA
09/2019
1Interleukin-6 (Interleukin 6)IBA
01/2019
1Cadherins (E-Cadherin)IBA
12/2018
1SurvivinIBA
10/2018
1triphosphoric acid (triphosphate)IBA
03/2018
1IonomycinIBA
03/2018
1Carrier Proteins (Binding Protein)IBA
03/2018
1OligomycinsIBA
01/2018
1DNA Nucleotidylexotransferase (Terminal Deoxynucleotidyl Transferase)IBA
01/2018
1Calcium-Calmodulin-Dependent Protein Kinase Type 2IBA
01/2018
1ThymidineIBA
04/2017
1AntioxidantsIBA
01/2017

Therapy/Procedure

5Therapeutics
01/2022 - 01/2015
5Drug Therapy (Chemotherapy)
09/2015 - 10/2012
1Transcutaneous Electric Nerve Stimulation (TENS)
01/2022